<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">FNS</journal-id><journal-title-group><journal-title>Food and Nutrition Sciences</journal-title></journal-title-group><issn pub-type="epub">2157-944X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/fns.2013.411150</article-id><article-id pub-id-type="publisher-id">FNS-37653</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Trans Fatty Acid Content of Iranian Edible Oils
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>annan</surname><given-names>Hajimahmoodi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sarvenaz</surname><given-names>Arami</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Marzieh</surname><given-names>Nosrati</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ghazaleh</surname><given-names>Moghaddam</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Naficeh</surname><given-names>Sadeghi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohammad</surname><given-names>Reza Oveisi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Behrooz</surname><given-names>Jannat</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fatemeh</surname><given-names>Zamani Mazdeh</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff4"><addr-line>Food and Drug Administration, Tehran University of Medical Sciences, Tehran, Iran</addr-line></aff><aff id="aff1"><addr-line>Department of Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran;Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran</addr-line></aff><aff id="aff3"><addr-line>Ministry of Health and Medical Education, Research Center, Tehran, Iran</addr-line></aff><aff id="aff2"><addr-line>Department of Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>hajimah@sina.tums.ac.ir(AH)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>10</month><year>2013</year></pub-date><volume>04</volume><issue>11</issue><fpage>1167</fpage><lpage>1174</lpage><history><date date-type="received"><day>May</day>	<month>6th,</month>	<year>2013</year></date><date date-type="rev-recd"><day>June</day>	<month>6th,</month>	<year>2013</year>	</date><date date-type="accepted"><day>June</day>	<month>13th,</month>	<year>2013</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   Clinical and epidemiologic studies showed that among dietary factors the type of fatty acids (FAs) in the diet plays an important role in determining risk of chronic disease. The aim of our study was to determine the levels of Trans FA (TFA) in edible oil samples consumed in Tehran, Iran analyzed by gas chromatograph (GC). The mean of total TFA was 0.45% ranging from (0.11% - 1.61%) for liquid frying oils and 2.92% ranging from (0.46% - 5.40%) for solid oils. The major TFA observed in these two groups was elaidic acid in solid oils. The highest content of total saturated fatty acid (SFA) was detected in solid oils with average of 32.07 and palmitic acid was the major SFA in these four groups. Linoleic and linolenic acid are the most important poly unsaturated fatty acid (PUFA). The variance in the percentage of TFA in the edible oils probably resulted from differences in the type of oils, quality, heating, processing technique and storage condition of the edible oils. The results indicated that, edible oils contain considerable proportions of trans fatty acids. Therefore, it is important to assess the content of TFA in edible oils in Iran. 
 
</p></abstract><kwd-group><kwd>Trans Fatty Acid; Gas Chromatography; Solid Oil; Liquid Frying Oil</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The interest in dietary fat is widespread, and fatty compound analysis is a basic requirement in testing food material [<xref ref-type="bibr" rid="scirp.37653-ref1">1</xref>]. Animal fats tend to have a larger proportion of long chain saturated acids and are solids at room temperature [<xref ref-type="bibr" rid="scirp.37653-ref2">2</xref>]. The different kinds of FA are saturated fatty acid (SFA), monounsaturated (MUFA), polyunsaturated (PUFA) and trans (TFA) [<xref ref-type="bibr" rid="scirp.37653-ref3">3</xref>]. The most widely used accurate and repeatable method for FA analysis is GC equipped with flame ionization detector (FID) [<xref ref-type="bibr" rid="scirp.37653-ref4">4</xref>].</p><p>TFAs are defined as unsaturated FA (UFA) with at least a double bond in the trans configuration resulting in a more rigid molecule close to a SFA [<xref ref-type="bibr" rid="scirp.37653-ref5">5</xref>]. Fats from plant sources contain a higher proportion of unsaturated acids and are often liquids at room temperature due to hydrogen bonding [<xref ref-type="bibr" rid="scirp.37653-ref6">6</xref>]. Industrial hydrogenation which is performed to improved texture, stability and other economically desirable properties is the major cause of TFA creation [<xref ref-type="bibr" rid="scirp.37653-ref7">7</xref>]. Also, microbial transformation of UFA in ruminants, heating and frying above 180˚ and deodorization of edible oil are the other causes of TFA creation [<xref ref-type="bibr" rid="scirp.37653-ref8">8</xref>]. Hydrogenation is a process that reduces the relative unsaturation of the oils and promotes geometric and positional isomeration [<xref ref-type="bibr" rid="scirp.37653-ref9">9</xref>]. Several clinical studies have shown that a TFA diet increase unfavorable LDL (low density lipoprotein)/HDL (high density lipoprotein) ratio and lipoprotein (a) and plasma triglyceride levels, which are independently associated with the increase risk of coronary heart disease (CHD) [<xref ref-type="bibr" rid="scirp.37653-ref10">10</xref>]. The risk of ischemic heart disease increases 25% by daily intake of TFA as little as 5 g [<xref ref-type="bibr" rid="scirp.37653-ref8">8</xref>]. Moreover, TFA intake promotes inflammation, increases body mass index, raises C-reactive protein, causes endothelial dysfunction and relates to the risk of diabetes. Replacing saturated or trans fat with polyunsaturated or monounsaturated fat is favorable in lowering serum cholesterol and reducing risk of CAD (Cardiac attack death) [<xref ref-type="bibr" rid="scirp.37653-ref11">11</xref>].</p><p>In Iran, TFA accounts 4.2% of all calories consumed by Iranians, which is much higher than US and many European populations do [<xref ref-type="bibr" rid="scirp.37653-ref12">12</xref>]. Between 11% and 39% of coronary heart disease referring to consumption of TFA and also, elimination of TFA in hydrogenated vegetable oils (HVOs) might be prevented 8% - 39% of cardiovascular disease events among Iranians [<xref ref-type="bibr" rid="scirp.37653-ref13">13</xref>]. In US populations TFA account for 2% - 3% of total energy intake [<xref ref-type="bibr" rid="scirp.37653-ref14">14</xref>].</p><p>In spite of the TFA disadvantages, limited data on the TFA contents of Iranian foods are available and it seems that the amount of TFA in edible oil requires more attention in developing countries [<xref ref-type="bibr" rid="scirp.37653-ref15">15</xref>].</p><p>Therefore, the aim of this study was to determine and compare TFA content in the branded liquid frying and solid oils that are commonly consumed by Iranian and also comparison of the achieved amount with approved standard in Iran and the other countries.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Sampling</title><p>Eight brands of liquid frying oils and four brands of solid oils that are commonly consumed in Iran were selected and each brand was coded with a letter (A, B, C, D, and…). Lot numbers were checked to ensure that each unit belonged to a different lot. All oil samples were stored, labeled and analyzed before expiry dates. Samples were selected to include the major manufacturers of the oils in Iran. The composition of studied oils was mixture of palm oil, soybean oil, canola oil, and sunflower oil. However solid oils contain more percentage of saturated fat.</p></sec><sec id="s2_2"><title>2.2. Reagents and Standards</title><p>All solvents and reagents were used of analytical grade. Methanol, n-Hexane, sodium hydroxide, methanolic boron trifluoride and sodium chloride were purchased from Merck, (Darmstadt, Germany).</p><p>The certified standard mixture of 37 component FA methyl ester C4-C24 was purchased from (Accuastandard, USA), also linoleic and linolenic acid methyl ester isomer were purchased from (Sigma, USA).</p></sec><sec id="s2_3"><title>2.3. Sample Preparation</title><p>Methyl-esterification of samples used in the analyses was performed by BF<sub>3</sub>-MeOH method according to AOCS (American oil chemist society) [<xref ref-type="bibr" rid="scirp.37653-ref16">16</xref>]. In to a 125 mL flask, one g of oil was weighted and added ten mL of 0.5 (N) methanolic sodium hydroxide solutions, the mixture was heated at 100˚C for 10 min, then 12 mL BF<sub>3</sub>-MeOH reagent was added, and heated for extra 2 min. After cooling five mL of n-hexane was added. The reaction was stopped by adding 15 mL saturated solution of NaCl and shaking the flask for about 15 seconds. One mL of the upper organic phase was selected and anhydrous Na<sub>2</sub>SO<sub>4</sub> was added. The sample solution was injected to the gas chromatography (GC) after filtering through 0.22 &#181;m disposable syringe filter.</p></sec><sec id="s2_4"><title>2.4. GC-FID Analysis</title><p>The GC-FID analyses were performed on an Agilent model 7890 GC instrument equipped with a flame ionization detector. A highly polar capillary column (100 m &#215; 0.25 mm i.d &#215; 0.25 &#181;m film thickness) of HP-88 (Agilent, USA) was used to separate the FAMEs. Nitrogen was used as the carrier gas at a flow rate of 1.0 mL/min. A split ratio of 100:1 was used and 1 &#181;L of the sample was injected into the GC for analysis. The following oven temperature program was used: 180˚C for 30 min, then increase to 200˚C at a rate of 1.5˚C/min and kept at 200˚C for 30 min. The temperature was set at 220˚C for the injector and at 250˚C for the detector. The samples were analyzed triplicate and the results were expressed as mean values &#177; standard deviation (SD).</p></sec><sec id="s2_5"><title>2.5. Data Analysis</title><p>Data were analyzed using statistical package for social sciences, version 16 (SPSS Inc., Chicago, IL, USA). Three independent oil samples of each cultivar were analyzed three times. Data are expressed as mean _ SDs. T-test was used for determining the differences between means inliquid frying oils and the solid oils. Statistical significance was set at p &lt; 0.05.</p></sec></sec><sec id="s3"><title>3. Results and Discussion</title><sec id="s3_1"><title>3.1. Liquid Frying Oils</title><p>The FA compositions of various brands of liquid frying oils in Iran are presented in <xref ref-type="table" rid="table1">Table 1</xref>. The mean of SFA in the brands ranged from 11.67% in C to 36.12% in A. Among the SFA palmitic acid presented the highest value ranging from 6.86% in C to 30.34% in D. High oleic oils (C18:1c) have better oxidative stability in deep frying applications and extended shelf life and reduced LDL [<xref ref-type="bibr" rid="scirp.37653-ref17">17</xref>]. Group A had maximum content of oleic (36.20%).</p><p><xref ref-type="table" rid="table1">Table 1</xref> shows that UFA ranged from 27.36% in A to 54.24% in C. Linoleic and linolenic acid are the most important PUFA. As nutritional point of view the amount of PUFA in oils is very important. Linoleic and linolenic have useful influence on human health and improve cardiovascular function. They also have positive effect on lipid profile [<xref ref-type="bibr" rid="scirp.37653-ref7">7</xref>]. Despite of these positive effects, high levels of multiple double bond FA increase oxidation oil sensitivity in liquid frying oil [<xref ref-type="bibr" rid="scirp.37653-ref17">17</xref>]. Therefore, high linolenic content was found in group C (3.85%) due to more oxidation tendency. According to the acceptable range of linolenic in Iran, standard reference and also Wolff report [<xref ref-type="bibr" rid="scirp.37653-ref18">18</xref>] on only C group with 3.85% mean percentage was</p></sec></sec></body><back><ref-list><title>References</title><ref id="scirp.37653-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">F. Priego-Capote, J. Ruiz-Jimenez, J. Garcia-Olmo and M. D. Luque de castro, “Fast Method for the Determination of Total Fat and Trans Fatty-Acids Content in Bakery Products Based on Microwave-Assisted Soxhlet Extrac  tion and Medium Infrared Spectroscopy Detection,” Ana  lytica Chimica Acta, Vol. 517, No. 1-2, 2004, pp. 13-20.  
http://dx.doi.org/10.1016/j.aca.2004.04.067</mixed-citation></ref><ref id="scirp.37653-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">L. Arab, “Biomarkers of Fat and Fatty Acid Intake,” ASNS, Vol. 133, No. 3, 2003, pp. 925-932.</mixed-citation></ref><ref id="scirp.37653-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">N. R. Matthan, F. K. Welty, P. H. Barrett, C. Harausz, G. G. Dolnikowski and J. S. Parks, et al., “Dietaryhydrogenated Fat Increases High-Density Lipoprotein Apo A-I Catabolism and Decreases Low-Density Lipoprotein Apo B-100 Catabolism in Hypercholesterolemic Women,” Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 24, No. 6, 2004, pp. 1092-1097.  
http://dx.doi.org/10.1161/01.ATV.0000128410.23161.be</mixed-citation></ref><ref id="scirp.37653-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">P. Juanéda, M. Ledoux and J. L. Sébédio, “Analytical Methods for Determination of Trans FA Content in Food,” European Journal of Lipid Science and Technol  ogy, Vol. 109, No. 9, 2007, pp. 901-917.  
http://dx.doi.org/10.1002/ejlt.200600277</mixed-citation></ref><ref id="scirp.37653-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">E. Larque, S. Zamora and A. Gil, “Dietary Trans Fatty Acids in Early Life: A Review,” Early Human Develop  ment, Vol. 65, No. 2, 2001, pp. 31-41.  
http://dx.doi.org/10.1016/S0378-3782(01)00201-8</mixed-citation></ref><ref id="scirp.37653-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">M. Tavella, G. Peterson, M. Espeche, E. Cavallero, L. Cipolla and L. Perego, et al.,“Trans Fatty Acid Content of a Selection of Foods in Argentina,” Food Chemistry, Vol. 69, No. 2, 2000, pp. 209-213.  
http://dx.doi.org/10.1016/S0308-8146(99)00257-5</mixed-citation></ref><ref id="scirp.37653-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">A. Baylin, X. Siles, A. Donovan-Palmer, X. Fernandez and H. Campos, “Fatty Acid Composition of Costa Rican Foods Including Trans Fatty Acid Content,” Journal of Food Composition and Analysis, Vol. 20, No. 3-4, 2007, pp. 182-192. http://dx.doi.org/10.1016/j.jfca.2006.01.004</mixed-citation></ref><ref id="scirp.37653-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">E. K. Richer, K. A. Shawish, M. R. Scheeder and P. C. Colombani, “Trans Fatty Acid Content of Selected Swiss Foods: The Transswiss Pilot Study,” Journal of Food Composition and Analysis, Vol. 22, No. 5, 2009, pp. 479-484. http://dx.doi.org/10.1016/j.jfca.2009.01.007</mixed-citation></ref><ref id="scirp.37653-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">A. Tekin, M. Cizmeci, H. Karabacak and M. Kayahan, “Trans FA and Solid Fat Contents of Margarines Mar  keted in Turkey,” American Oil Chemists’ Society, Vol. 79, No. 5, 2002, pp. 443-445.  
http://dx.doi.org/10.1007/s11746-002-0503-9</mixed-citation></ref><ref id="scirp.37653-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">C. A. Martin, R. Carapelli, J. V. Visantainer, M. Matsushita and N. E. Souza, “Trans Fatty Acid Content of Brazilian Biscuits,” Food Chemistry, Vol. 93, No. 3, 2005, pp. 445-448.  
http://dx.doi.org/10.1016/j.foodchem.2004.10.022</mixed-citation></ref><ref id="scirp.37653-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">D. Mozaffarian, M. Abdollahi, H. Campos, A. HoushiarRad and W.C. Willett, “Consumption of Trans Fats and Estimated Effects on Coronary Heart Disease in Iran,” European Journal of Clinical Nutrition, Vol. 61, 2007, pp. 1004-1010. http://dx.doi.org/10.1038/sj.ejcn.1602608</mixed-citation></ref><ref id="scirp.37653-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">S. Asgary, B. Nazari, N. Sarrafzadegan, S. Saberi, L. Azadbakht and A. Esmaillzadeh, “Fatty Acid Composition of Commercially Available Iranian Edible Oils,” Journal of Research in Medical Sciences, Vol. 14, No. 4, 2009, pp. 211-215.</mixed-citation></ref><ref id="scirp.37653-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">D. Mozaffarian, M. B. Katan, A. Ascherio, M. J. Stamp  fer and W. C. Willett, “Trans Fatty Acids and Cardiovas  cular Disease,” New England Journal of Medicine, Vol. 354, No. 15, 2006, pp. 1601-1613.  
http://dx.doi.org/10.1056/NEJMra054035</mixed-citation></ref><ref id="scirp.37653-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">D. B. Allison, S. K. Egan, L. M. Barraj, C. Caughman, M. Infante and J. T. Heimbach, “Estimated Intakes of Trans Fatty and Other FAs in the US Population,” Journal of the American Dental Association, Vol. 99, No. 2, 1999, pp. 166-174.  
http://dx.doi.org/10.1016/S0002-8223(99)00041-3</mixed-citation></ref><ref id="scirp.37653-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">S. Asgary, B. Nazari, N. Sarrafzadegan, S. Saberi, L. Azadbakht and A. Esmaillzadeh, et al., “Evaluation of FA Content of Some Iranian Fast Foods with Emphasis on Trans FAs,” Journal of Clinical Nutrition, Vol. 18, No. 2, 2009, pp. 187-192.</mixed-citation></ref><ref id="scirp.37653-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">AOCS Official Method Ce, “Preparations of Methyl Esters of Fatty Acids,” 1997, pp. 2-66.</mixed-citation></ref><ref id="scirp.37653-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">M. T. Tarrago-Trani, K. M. Phillips, L. E. Lemar and J. M. Holdon, “New and Existing Oils and Fats Used in Products with Reduced Trans-Fatty Acid Content,” Jour  nal of the American Dietetic Association, Vol. 106, No. 6, 2006, pp. 867-880.  
http://dx.doi.org/10.1016/j.jada.2006.03.010</mixed-citation></ref><ref id="scirp.37653-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">R. L. Wolff, “Are Trans Isomers of Alpha-Linolenic Acid of Nutritional Significance for Certain Populations,” Lip  ids, Vol. 37, No. 12, 2002, pp. 1147-1148.  
http://dx.doi.org/10.1007/s11745-002-1012-1</mixed-citation></ref><ref id="scirp.37653-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">A. Kandhro, S. T. H. Sherazi, S. A. Mahesar, M. Bhanger, Y. Talpur and A. Rauf, “GC-MS Quantification of Fatty Acid Profile Including Trans FA in the Locally Manufac  tured Margarines of Pakistan,” Food Chemistry, Vol. 109, No. 1, 2008, pp. 207-211.  
http://dx.doi.org/10.1016/j.foodchem.2007.12.029</mixed-citation></ref><ref id="scirp.37653-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">K. Hulsof, M. A. Van Erp-Baart and M. Anttolanin, et al., “Intake of FAs in Western Europe with Emphasis on Trans FAs: The TRANSFAIR Study,” European Journal of Clinical Nutrition, Vol. 53, No. 2, 1999, pp. 143-157.  
http://dx.doi.org/10.1038/sj.ejcn.1600692</mixed-citation></ref><ref id="scirp.37653-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">T. Leth, H. G. Jensen, A. A. Mikkelsen and A. Bysted, “The Effect of the Regulation on Trans FA Content in Danish Food,” Atherosclerosis Supplements, Vol. 7, No. 2, 2006, pp. 53-56.  
http://dx.doi.org/10.1016/j.atherosclerosissup.2006.04.019</mixed-citation></ref><ref id="scirp.37653-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">M. B. Katan, “Exit Trans FAs,” Lancet, Vol. 346, No. 8985, 1995, pp. 1245-1246.  
http://dx.doi.org/10.1016/S0140-6736(95)91858-2</mixed-citation></ref><ref id="scirp.37653-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">G. Ghafoorunissa, “Role of Trans FAs in Health and Challenges to Their Reduction in Indian Foods,” Asia Pacific Journal of Clinical Nutrition, Vol. 17, No. 1, 2008, pp. 212-215.</mixed-citation></ref></ref-list></back></article>